BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malhi GS, Bell E, Bassett D, Boyce P, Bryant R, Hazell P, Hopwood M, Lyndon B, Mulder R, Porter R, Singh AB, Murray G. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2021;55:7-117. [PMID: 33353391 DOI: 10.1177/0004867420979353] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 52.0] [Reference Citation Analysis]
Number Citing Articles
1 Yung AR, Hockey M, Grosman A, Rocks T. Role of Diet in Depression in Young People: Recommendations for Implementation in Practice. Psychiatric Annals 2022;52:56-61. [DOI: 10.3928/00485713-20220127-01] [Reference Citation Analysis]
2 Malhi GS, Bell E, Singh AB, Bassett D, Berk M, Boyce P, Bryant R, Gitlin M, Hamilton A, Hazell P, Hopwood M, Lyndon B, McIntyre RS, Morris G, Mulder R, Porter R, Yatham LN, Young A, Murray G. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: Major depression summary.Bipolar Disord. 2020;22:788-804. [PMID: 33320412 DOI: 10.1111/bdi.13035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
3 English T, Castle D. Treating schizophrenia: Should we emphasise 'first do no harm'? Aust N Z J Psychiatry 2021;:48674211025696. [PMID: 34144645 DOI: 10.1177/00048674211025696] [Reference Citation Analysis]
4 Svardal CA, Waldie K, Milne B, Morton SM, D'Souza S. Prevalence of antidepressant use and unmedicated depression in pregnant New Zealand women. Aust N Z J Psychiatry 2021;:48674211025699. [PMID: 34260316 DOI: 10.1177/00048674211025699] [Reference Citation Analysis]
5 Amad A, Fovet T. rTMS for depression: The difficult transition from research to clinical practice. Aust N Z J Psychiatry 2021;:48674211011242. [PMID: 33982627 DOI: 10.1177/00048674211011242] [Reference Citation Analysis]
6 McCarthy MJ, Gottlieb JF, Gonzalez R, McClung CA, Alloy LB, Cain S, Dulcis D, Etain B, Frey BN, Garbazza C, Ketchesin KD, Landgraf D, Lee HJ, Marie-Claire C, Nusslock R, Porcu A, Porter R, Ritter P, Scott J, Smith D, Swartz HA, Murray G. Neurobiological and behavioral mechanisms of circadian rhythm disruption in bipolar disorder: A critical multi-disciplinary literature review and agenda for future research from the ISBD task force on chronobiology. Bipolar Disord 2021. [PMID: 34850507 DOI: 10.1111/bdi.13165] [Reference Citation Analysis]
7 Malhi GS. Thing one and thing two1: What 'Doctors use' to doctor you? Aust N Z J Psychiatry 2021;55:536-47. [PMID: 34080455 DOI: 10.1177/00048674211022602] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Dean RL, Marquardt T, Hurducas C, Spyridi S, Barnes A, Smith R, Cowen PJ, McShane R, Hawton K, Malhi GS, Geddes J, Cipriani A. Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder. Cochrane Database Syst Rev 2021;10:CD011611. [PMID: 34623633 DOI: 10.1002/14651858.CD011611.pub3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Campos AI, Mulcahy A, Thorp JG, Wray NR, Byrne EM, Lind PA, Medland SE, Martin NG, Hickie IB, Rentería ME. Understanding genetic risk factors for common side effects of antidepressant medications. Commun Med 2021;1. [DOI: 10.1038/s43856-021-00046-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sørensen A, Juhl Jørgensen K, Munkholm K. Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review. Therapeutic Advances in Psychopharmacology 2022;12:204512532110676. [DOI: 10.1177/20451253211067656] [Reference Citation Analysis]
11 de Oliveira Costa J, Gillies MB, Schaffer AL, Peiris D, Zoega H, Pearson SA. Changes in antidepressant use in Australia: A nationwide analysis (2015-2021). Aust N Z J Psychiatry 2022;:48674221079740. [PMID: 35176912 DOI: 10.1177/00048674221079740] [Reference Citation Analysis]
12 Anaf G, Hill M, Prager S, Elton V, Morris P. Clinical practice guidelines, psychotherapy and implications for psychiatry. Australas Psychiatry 2021;:10398562211054661. [PMID: 34781773 DOI: 10.1177/10398562211054661] [Reference Citation Analysis]
13 Haitana T, Pitama S, Cormack D, Clark MTR, Lacey C. Culturally competent, safe and equitable clinical care for Ma¯ori with bipolar disorder in New Zealand: The expert critique of Ma¯ori patients and Wha¯nau. Aust N Z J Psychiatry 2021;:48674211031490. [PMID: 34263663 DOI: 10.1177/00048674211031490] [Reference Citation Analysis]
14 McAllister-Williams RH, Aaronson ST, Conway CR, Demyttenaere K, Fitzgerald PB, Loo CK, Mitchell PB, Rush AJ, Sackeim HA, Young AH. The 'difficult-to-treat depression' and the 'response paradigm' models: Implications and relevance to patient management. Aust N Z J Psychiatry 2021;55:824-5. [PMID: 33971766 DOI: 10.1177/00048674211013090] [Reference Citation Analysis]
15 Douglas KM, Inder ML, Crowe MT, Jordan J, Carlye D, Lacey C, Beaglehole B, Mulder R, Eggleston K, Donovan KA, Frampton CMA, Bowie CR, Porter RJ. Randomised controlled trial of Interpersonal and Social Rhythm Therapy and group-based Cognitive Remediation versus Interpersonal and Social Rhythm Therapy alone for mood disorders: study protocol. BMC Psychiatry 2022;22:115. [PMID: 35164720 DOI: 10.1186/s12888-022-03747-z] [Reference Citation Analysis]
16 Harari E, Grant DC. Clinical wisdom, science and evidence: The neglected gifts of psychodynamic thinking. Aust N Z J Psychiatry 2022;:48674221077622. [PMID: 35172624 DOI: 10.1177/00048674221077622] [Reference Citation Analysis]
17 Dawson SL, Finlay-jones A, Ball L, Rocks T, Jacka F. Supporting Maternal and Child Mental Health Through Dietary Changes Focused on the Gut Microbiota. Psychiatric Annals 2022;52:51-5. [DOI: 10.3928/00485713-20220126-01] [Reference Citation Analysis]
18 Galbally M, Woods N, Snellen M. How clinicians can support women in making decisions about psychopharmacological treatments in pregnancy. World Psychiatry 2022;21:149-51. [PMID: 35015366 DOI: 10.1002/wps.20937] [Reference Citation Analysis]
19 Malhi GS, Bell E, Murray G, Boyce P, Lyndon B, Bassett D, Mulder R, Hopwood M, Porter R, Singh AB. The positioning of rTMS. Aust N Z J Psychiatry 2021;55:125-8. [DOI: 10.1177/0004867421993541] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
20 Malhi GS, Bell E, Bassett D, Boyce P, Hopwood M, Murray G, Porter R, Singh A, Mulder R. Virtual guidance: Mood disorders guidelines '2. Oh'! Aust N Z J Psychiatry 2021;:48674211010244. [PMID: 33938288 DOI: 10.1177/00048674211010244] [Reference Citation Analysis]
21 Hsu C, Tsai S, Tseng P, Liang C, Vieta E, Carvalho AF, Stubbs B, Kao H, Tu Y, Lin P. Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis. European Neuropsychopharmacology 2022;58:20-9. [DOI: 10.1016/j.euroneuro.2022.01.112] [Reference Citation Analysis]
22 Malhi GS, Bell E, Mannie Z. What are the real costs of rTMS? Aust N Z J Psychiatry 2021;55:841-3. [PMID: 34250819 DOI: 10.1177/00048674211023969] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Dargél AA. Beyond evidence and toward long-term and individualized management of bipolar disorder in real-world practice. Bipolar Disord 2021;23:511-2. [PMID: 33690964 DOI: 10.1111/bdi.13072] [Reference Citation Analysis]
24 Lugg W. RANZCP clinical practice guidelines - time to digitise. Aust N Z J Psychiatry 2021;55:1114-6. [PMID: 33951951 DOI: 10.1177/00048674211010341] [Reference Citation Analysis]
25 Groves SJ, Douglas KM, Milanovic M, Bowie CR, Porter RJ. Systematic review of the effects of evidence-based psychotherapies on neurocognitive functioning in mood disorders. Aust N Z J Psychiatry 2021;:48674211031479. [PMID: 34278831 DOI: 10.1177/00048674211031479] [Reference Citation Analysis]
26 Bell E, Boyce P, Porter RJ, Bryant RA, Malhi GS. Irritability in Mood Disorders: Neurobiological Underpinnings and Implications for Pharmacological Intervention. CNS Drugs 2021;35:619-41. [PMID: 34019255 DOI: 10.1007/s40263-021-00823-y] [Reference Citation Analysis]
27 Hsu CW, Carvalho AF, Tsai SY, Wang LJ, Tseng PT, Lin PY, Tu YK, Vieta E, Solmi M, Hung CF, Kao HY. Lithium concentration and recurrence risk during maintenance treatment of bipolar disorder: Multicenter cohort and meta-analysis. Acta Psychiatr Scand 2021. [PMID: 34227095 DOI: 10.1111/acps.13346] [Reference Citation Analysis]
28 Bassett D, Boyce P, Lyndon B, Mulder R, Parker G, Porter R, Singh A, Bell E, Hamilton A, Morris G, Malhi GS. Guidelines for the management of psychosis in the context of mood disorders. Schizophrenia Research 2022;241:187-96. [DOI: 10.1016/j.schres.2022.01.047] [Reference Citation Analysis]
29 Fifer S, Puig A, Sequeira V, Acar M, Ng CH, Blanchard M, Cabrera A, Freemantle J, Grunfeld J. Understanding Treatment Preferences of Australian Patients Living with Treatment-Resistant Depression. Patient Prefer Adherence 2021;15:1621-37. [PMID: 34321870 DOI: 10.2147/PPA.S311699] [Reference Citation Analysis]
30 Baghaei N, Chitale V, Hlasnik A, Stemmet L, Liang HN, Porter R. Virtual Reality for Supporting the Treatment of Depression and Anxiety: Scoping Review. JMIR Ment Health 2021;8:e29681. [PMID: 34554097 DOI: 10.2196/29681] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Rabelo JL, Cruz BF, Ferreira JDR, Viana BM, Barbosa IG. Psychoeducation in bipolar disorder: A systematic review. World J Psychiatr 2021; 11(12): 1407-1424 [DOI: 10.5498/wjp.v11.i12.1407] [Reference Citation Analysis]
32 Veraart JKE, Smith-Apeldoorn SY, Bakker IM, Visser BAE, Kamphuis J, Schoevers RA, Touw DJ. Pharmacodynamic interactions between ketamine and psychiatric medications used in the treatment of depression: a systematic review. Int J Neuropsychopharmacol 2021:pyab039. [PMID: 34170315 DOI: 10.1093/ijnp/pyab039] [Reference Citation Analysis]
33 Malhi GS, Bell E. Re-positioning rTMS: From ECT magic, to magical thinking! Aust N Z J Psychiatry 2021;:48674211016050. [PMID: 34041927 DOI: 10.1177/00048674211016050] [Reference Citation Analysis]
34 Natale A, Mineo L, Fusar-poli L, Aguglia A, Rodolico A, Tusconi M, Amerio A, Serafini G, Amore M, Aguglia E. Mixed Depression: A Mini-Review to Guide Clinical Practice and Future Research Developments. Brain Sciences 2022;12:92. [DOI: 10.3390/brainsci12010092] [Reference Citation Analysis]
35 Solé B, Martínez-Aran A, Vieta E, Torrent C. Commentary on "The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary". Bipolar Disord 2021;23:513-4. [PMID: 33706410 DOI: 10.1111/bdi.13073] [Reference Citation Analysis]
36 Sweetman A, Lack L, Van Ryswyk E, Vakulin A, Reed RL, Battersby MW, Lovato N, Adams RJ. Co-occurring depression and insomnia in Australian primary care: recent scientific evidence. Med J Aust 2021;215:230-6. [PMID: 34392547 DOI: 10.5694/mja2.51200] [Reference Citation Analysis]
37 Malhi GS, Bell E, Mannie Z, Boyce P, Hopwood M, Bassett D, Mulder R, Porter RJ, Lyndon B. rTMS and treatment-resistant depression: The need to consider class action! Aust N Z J Psychiatry 2021;:48674211025094. [PMID: 34250832 DOI: 10.1177/00048674211025094] [Reference Citation Analysis]
38 Wang Y, Chew QH, Lin SK, Yang SY, Ouyang WC, Chen CK, Park SC, Jang OJ, Park JH, Chee KY, Ding KS, Chong J, Zhang L, Li K, Zhu X, Jatchavala C, Pariwatcharakul P, Kallivayalil RA, Grover S, Avasthi A, Ansari M, Maramis MM, Aung PP, Sartorius N, Xiang YT, Tan CH, Chong MY, Park YC, Kato TA, Shinfuku N, Baldessarini RJ, Sim K. Dosing of Mood Stabilizers for Bipolar Disorder Patients in the Research on Asian Psychotropic Prescription Patterns Consortium Study. J Clin Psychopharmacol 2022. [PMID: 35384905 DOI: 10.1097/JCP.0000000000001549] [Reference Citation Analysis]
39 Wong VW, Ho FY, Shi NK, Sarris J, Ng CH, Tam OK. Lifestyle medicine for anxiety symptoms: A meta-analysis of randomized controlled trials. J Affect Disord 2022:S0165-0327(22)00495-5. [PMID: 35523299 DOI: 10.1016/j.jad.2022.04.151] [Reference Citation Analysis]
40 Lugg W. The biopsychosocial model - history, controversy and Engel. Australas Psychiatry 2021;:10398562211037333. [PMID: 34748708 DOI: 10.1177/10398562211037333] [Reference Citation Analysis]
41 Fitzgerald PB, Gill S, Hussain S, Sarma S, Chamoli S, Weiss A, Garside D, Purushothaman S, Fasnacht M, Simpson B, Csizmadia T, Dean C, Loo C. The place of non-invasive brain stimulation in the RANZCP clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2021;55:349-54. [PMID: 33797285 DOI: 10.1177/00048674211004344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
42 Malhi GS, Bell E, Boyce P, Hopwood M, Murray G, Mulder R, Porter R, Singh A, Bassett D. The 2020 mood disorders clinical practice guidelines: Translating evidence into practice with both style and substance. Aust N Z J Psychiatry 2021;55:919-20. [PMID: 33938293 DOI: 10.1177/00048674211010233] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Campos AI, Ngo TT, Medland SE, Wray NR, Hickie IB, Byrne EM, Martin NG, Rentería ME. Genetic risk for chronic pain is associated with lower antidepressant effectiveness: Converging evidence for a depression subtype. Aust N Z J Psychiatry 2021;:48674211031491. [PMID: 34266302 DOI: 10.1177/00048674211031491] [Reference Citation Analysis]
44 Au-Yeung SK, Griffiths J, Roberts S, Edwards C, Yu LM, Bogacz R, Rendell J, Attenburrow MJ, Watson S, Chan F, Cipriani A, Cleare A, Harmer CJ, Kessler D, Evans J, Lewis G, Singh I, Simon J, Harrison PJ, Cowen P, Shanyinde M, Geddes J, Browning M. PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression. Evid Based Ment Health 2021:ebmental-2021-300282. [PMID: 34810175 DOI: 10.1136/ebmental-2021-300282] [Reference Citation Analysis]
45 Taylor RW, Cleare AJ. The RANZCP 2020 guideline summaries and the need for standardised guideline development. Bipolar Disord 2021. [PMID: 33938101 DOI: 10.1111/bdi.13092] [Reference Citation Analysis]
46 Kahawage P, Crowe M, Gottlieb J, Swartz HA, Yatham LN, Bullock B, Inder M, Porter R, Nierenberg AA, Meesters Y, Gordjin M, Haarman BCM, Murray G. Adrift in time: the subjective experience of circadian challenge during COVID-19 amongst people with mood disorders. Chronobiol Int 2021;:1-11. [PMID: 34565268 DOI: 10.1080/07420528.2021.1967971] [Reference Citation Analysis]
47 Judd F, Hill R, Galbally M, Buist A. Underestimating the complexity of managing mood disorders in pregnancy: Commentary on the 2020 RANZCP Clinical Practice Guidelines for mood disorders. Aust N Z J Psychiatry 2021;55:1203-5. [PMID: 34407627 DOI: 10.1177/00048674211040715] [Reference Citation Analysis]
48 Malhi GS, Bell E, Bassett D, Boyce P, Hopwood M, Murray G, Mulder R, Singh A, Porter R. The 2020 mood disorders clinical practice guidelines: Dazzlingly bedazzling! Aust N Z J Psychiatry 2021;:48674211010262. [PMID: 33938287 DOI: 10.1177/00048674211010262] [Reference Citation Analysis]
49 Malhi GS, Bell E, Bassett D, Boyce P, Bryant R, Hazell P, Hopwood M, Lyndon B, Mulder R, Porter R, Singh AB, Murray G. An Evidence-Based Perspective on The 2020 Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines. Australas Psychiatry 2022;:10398562221100703. [PMID: 35508360 DOI: 10.1177/10398562221100703] [Reference Citation Analysis]
50 Parker G. Polarised views about bipolar disorder(s): A critique of the 2020 College guidelines for mood disorders. Aust N Z J Psychiatry 2021;55:548-52. [PMID: 34015972 DOI: 10.1177/00048674211020095] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Kahawage P, Bullock B, Meyer D, Gottlieb J, Crowe M, Swartz HA, Yatham LN, Inder M, Porter RJ, Nierenberg AA, Meesters Y, Gordijn M, Haarman BCM, Murray G. Social Rhythm Disruption is Associated with Greater Depressive Symptoms in People with Mood Disorders: Findings from a Multinational Online Survey During COVID-19. Can J Psychiatry. [DOI: 10.1177/07067437221097905] [Reference Citation Analysis]
52 Lugg W. The case for discontinuation of the 'discontinuation syndrome'. Aust N Z J Psychiatry 2022;56:93-5. [PMID: 34461750 DOI: 10.1177/00048674211043443] [Reference Citation Analysis]
53 Butterworth P, New SC, Schilling C, Saxby K, Petrie D, Wong C. Dynamics of Mental Health and Healthcare Use among Children and Young Adults. Australian Economic Review 2021;54:130-42. [DOI: 10.1111/1467-8462.12413] [Reference Citation Analysis]
54 Nussbaumer-Streit B, Thaler K, Chapman A, Probst T, Winkler D, Sönnichsen A, Gaynes BN, Gartlehner G. Second-generation antidepressants for treatment of seasonal affective disorder. Cochrane Database Syst Rev 2021;3:CD008591. [PMID: 33661528 DOI: 10.1002/14651858.CD008591.pub3] [Reference Citation Analysis]
55 Rosenman S. The dazzling guidelines. Aust N Z J Psychiatry 2021;:48674211037886. [PMID: 34414797 DOI: 10.1177/00048674211037886] [Reference Citation Analysis]
56 . Antidepressants and sexual adverse effects. Aust Prescr 2021;44:77. [PMID: 34211243 DOI: 10.18773/austprescr.2021.023] [Reference Citation Analysis]
57 Malhi GS, Bell E. Channelling a response to difficult-to-treat depression: A need for ratiocination, not rash assassination! Aust N Z J Psychiatry 2021;55:825-7. [PMID: 34058830 DOI: 10.1177/00048674211017226] [Reference Citation Analysis]
58 Sørensen A, Ruhé HG, Munkholm K. The relationship between dose and serotonin transporter occupancy of antidepressants-a systematic review. Mol Psychiatry 2021. [PMID: 34548628 DOI: 10.1038/s41380-021-01285-w] [Reference Citation Analysis]
59 Marx W, Lane MM, Hockey M, Aslam H, Walder K, Borsini A, Firth J, Pariante CM, Berding K, Cryan JF, Clarke G, Craig JM, Su KP, Mischoulon D, Gomez-Pinilla F, Foster JA, Cani PD, Thuret S, Staudacher HM, Sánchez-Villegas A, Arshad H, Akbaraly T, O'Neil A, Jacka FN. Diet and depression: future needs to unlock the potential. Mol Psychiatry 2021. [PMID: 34754110 DOI: 10.1038/s41380-021-01360-2] [Reference Citation Analysis]
60 Leichsenring F, Luyten P, Abbass A, Steinert C. Psychodynamic therapy of depression. Aust N Z J Psychiatry 2021;:48674211031481. [PMID: 34240645 DOI: 10.1177/00048674211031481] [Reference Citation Analysis]
61 Malhi GS, Bell E, Boyce P, Bassett D, Berk M, Bryant R, Gitlin M, Hamilton A, Hazell P, Hopwood M, Lyndon B, Mcintyre RS, Morris G, Mulder R, Porter R, Singh AB, Yatham LN, Young A, Murray G. The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary. Bipolar Disord 2020;22:805-21. [DOI: 10.1111/bdi.13036] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
62 Gomes FA, Cerqueira RO, Lee Y, Mansur RB, Kapczinski F, McIntyre RS, Yatham LN, Berk M, Milev R, Brietzke E. What not to use in bipolar disorders: a systematic review of non-recommended treatments in clinical practice guidelines. J Affect Disord 2021:S0165-0327(21)01225-8. [PMID: 34758372 DOI: 10.1016/j.jad.2021.11.007] [Reference Citation Analysis]
63 Wrobel AL, Jayasinghe A, Russell SE, Marx W, Alameda L, Dean OM, Cotton SM, Berk M, Turner A. The influence of childhood trauma on the treatment outcomes of pharmacological and/or psychological interventions for adolescents and adults with bipolar disorder: A systematic review and meta-analysis. J Affect Disord 2022;296:350-62. [PMID: 34606813 DOI: 10.1016/j.jad.2021.09.103] [Reference Citation Analysis]
64 Malhi GS, Bell E. Managing mixed mood states by maintaining a maintenance mindset? Aust N Z J Psychiatry 2021;55:329-31. [PMID: 33709815 DOI: 10.1177/0004867421999432] [Reference Citation Analysis]
65 Malhi GS. 21 st year of the 21 st century: And still, we need guidelines? Aust N Z J Psychiatry 2021;55:5-6. [DOI: 10.1177/0004867420981654] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Solly EJ, Clough M, Foletta P, White OB, Fielding J. The Psychiatric Symptomology of Visual Snow Syndrome. Front Neurol 2021;12:703006. [PMID: 34393980 DOI: 10.3389/fneur.2021.703006] [Reference Citation Analysis]
67 Malhi GS, Bell E. Questions in psychiatry (QuiP): Is paediatric bipolar disorder a valid diagnosis? Bipolar Disord 2021;23:297-300. [PMID: 33915004 DOI: 10.1111/bdi.13089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Bayes A, Dong V, Martin D, Alonzo A, Kabourakis M, Loo C. Ketamine treatment for depression: A model of care. Aust N Z J Psychiatry 2021;:48674211039166. [PMID: 34384256 DOI: 10.1177/00048674211039166] [Reference Citation Analysis]
69 Carter JD, Jordan J, McIntosh VV, Frampton CM, Lacey C, Porter RJ, Mulder RT. Long-term efficacy of metacognitive therapy and cognitive behaviour therapy for depression. Aust N Z J Psychiatry 2021;:48674211025686. [PMID: 34250846 DOI: 10.1177/00048674211025686] [Reference Citation Analysis]
70 Fitzgerald PB, Gill S, Breakspear M, Kulkarni J, Chen L, Pridmore S, Purushothaman S, Galletly C, Clarke P, Ng F, Hussain S, Chamoli S, Csizmadia T, Tolan P, Cocchi L, Ibrahim Oam S, Shankar K, Sarma S, Lau M, Loo C, Yadav T, Hoy KE. Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again. Aust N Z J Psychiatry 2021;:48674211068788. [PMID: 34969310 DOI: 10.1177/00048674211068788] [Reference Citation Analysis]
71 Bourke M, Patten RK, Dash S, Pascoe M, Craike M, Firth J, Bailey A, Jacka F, Parker AG. The Effect of Interventions That Target Multiple Modifiable Health Behaviors on Symptoms of Anxiety and Depression in Young People: A Meta-Analysis of Randomized Controlled Trials. J Adolesc Health 2021:S1054-139X(21)00401-8. [PMID: 34580029 DOI: 10.1016/j.jadohealth.2021.08.005] [Reference Citation Analysis]
72 Malhi GS, Bell E, Mannie Z, Bassett D, Boyce P, Hopwood M, Mulder R, Porter RJ, Singh AB, Lyndon B. Profiling rTMS: A critical response. Aust N Z J Psychiatry 2021;55:355-65. [PMID: 33797287 DOI: 10.1177/00048674211006192] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
73 Malhi GS, Bell E. A key clinical consideration: antidepressant withdrawal or illness relapse? BJPsych advances. [DOI: 10.1192/bja.2022.18] [Reference Citation Analysis]
74 Rosenman SJ. The clinical practice guidelines. Aust N Z J Psychiatry 2021;55:1116. [PMID: 34011190 DOI: 10.1177/00048674211010334] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Douglas KM, Fenton AJ, Eggleston K, Porter RJ. Rate of polycystic ovary syndrome in mental health disorders: a systematic review. Arch Womens Ment Health 2021. [PMID: 34499230 DOI: 10.1007/s00737-021-01179-4] [Reference Citation Analysis]
76 Marx W, Jacka F, O'Neil A. Lifestyle-based mental health care in psychiatry: Translating evidence into practice. Aust N Z J Psychiatry 2021;55:641-3. [PMID: 33977787 DOI: 10.1177/00048674211011250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Korgaonkar MS. Precision in psychiatry-A roadmap to translate neurobiological measures to the clinic. Bipolar Disord 2021;23:747-50. [PMID: 34932256 DOI: 10.1111/bdi.13160] [Reference Citation Analysis]
78 Brinsley J, Smout M, Girard D, Davison K. Acute mood and cardiovascular responses to moderate intensity vinyasa yoga, static yin yoga and aerobic exercise in people with depression and/or anxiety disorders: A 5-arm randomised controlled trial. Mental Health and Physical Activity 2022;22:100450. [DOI: 10.1016/j.mhpa.2022.100450] [Reference Citation Analysis]